Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Pierre Branger

4PUBLICATIONS
44CO-AUTHORS
OptometryPredictive and prognostic markersHaematological tumoursNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Apr 01, 2026
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS.

Apolline Tournier, Antoine Gavoille, Julie Pique

|Jul 11, 2024
Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study.

Romain Deschamps, Jessica Guillaume, Jonathan Ciron

|Feb 12, 2024
Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis.

Géraldine Androdias, Louise Noroy, Dimitri Psimaras

|Jun 20, 2020
Relapses During High-Dose Biotin Treatment in Progressive Multiple Sclerosis: a Case-Crossover and Propensity Score-Adjusted Prospective Cohort.

Pierre Branger, Jean-Jacques Parienti, Nathalie Derache

Pageof 1

Frequent Collaborators

3 joint publications

Jonathan Ciron

3 joint publications

Elisabeth Maillart

3 joint publications

Romain Marignier

2 joint publications

David Axel Laplaud

2 joint publications

Julie Pique

2 joint publications

Nicolas Collongues

2 joint publications

Philippe Kerschen

2 joint publications

Bertrand Audoin

2 joint publications

Romain Deschamps

2 joint publications

Sandra Vukusic

Frequent Collaborators

3 joint publications

Jonathan Ciron

3 joint publications

Elisabeth Maillart

3 joint publications

Romain Marignier

2 joint publications

David Axel Laplaud

Top Related Videos

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on : Jun 29, 2016

14.6K
Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
03:07

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

Published on : Jul 12, 2024

924
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on : Sep 12, 2016

12.3K
See more related videos

Top Related Videos

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on : Jun 29, 2016

14.6K
Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
03:07

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

Published on : Jul 12, 2024

924
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on : Sep 12, 2016

12.3K
See more related videos